NCT06619301View on ClinicalTrials.gov

RCT Glargine vs NPH for Treatment of DM in Pregnancy

PHASE3RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

January 1, 2027

Conditions
Diabetes Mellitus in PregnancyType 2 Diabetes Mellitus (T2DM)Gestational Diabetes Mellitus, Class A2
Interventions
DRUG

Insulin glargine

Insulin Glargine is regularly used outside of pregnancy and its efficacy is well documented. It is a current medication we regularly use in pregnancy, however, there is limited data for comparison to the standard, NPH.

DRUG

insulin NPH

Insulin NPH is a current medication used in pregnancy for diabetes mellitus. It has been used as the standard form of insulin.

Trial Locations (1)

60153

RECRUITING

Loyola University Medical Center, Maywood

All Listed Sponsors
lead

Loyola University

OTHER